News

Filter by Category

All Blog Events Newsletters Podcasts Posters Publications Webinars Workshops

Filter by Program

Filter by Publish Date

July 16, 2025

Critical Path Institute Appoints Dr. Aoife Brennan to Board of Directors

C-Path today announced the appointment of Aoife Brennan, M.D., to its Board of Directors. Dr. Brennan brings...

July 16, 2025

C-Path’s Translational Therapeutics Accelerator Announces $200,000 Grant for Drug Development Project in Inflammatory Bowel Disease

C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $200,000 grant to Carlos Subauste, M.D....

July 9, 2025

C-Path’s Kristen Swingle Named a “Woman Leading the Region” by BizTucson

C-Path) is proud to announce that President and Chief Operating Officer Kristen Swingle, M.S., has been named a 2025 BizTucson..

July 9, 2025

Celebrating 20 Years of Impact: C-Path Featured in Special BizTucson Anniversary Issue

This year, C-Path proudly marks 20 years of advancing regulatory science and reshaping how new treatments are developed...

June 20, 2025

C-Path Launches Global Collaborative to Advance Drug Development for Neonatal Brain Injury

C-Path, through its International Neonatal Consortium (INC), is proud to announce the official launch of the Neonatal Brain...

June 20, 2025

C-Path’s T1D Consortium to Release a Clinical Trial Simulation Tool for New-Onset Trial Design

C-Path's Type 1 Diabetes Consortium today announced the release of a pilot version of their regulatory-grade new-onset clinical...

June 18, 2025

C-Path’s Translational Therapeutics Accelerator Announces New Grant Award for Drug Development Project in Type 1 Diabetes

C-Path's Translational Therapeutics Accelerator (TRxA) proudly announced a $250,000 grant...

May 29, 2025

Critical Path Institute and Citizen Health Partner to Accelerate Drug Development for Neuromuscular Disorders

C-Path, a global nonprofit accelerating drug development through data science and regulatory...

May 27, 2025

C-Path Welcomes Avidity Biosciences as Newest Member to Duchenne Consortium

C-Path is excited to welcome Avidity Biosciences as a new member of the Duchenne Regulatory Science Consortium (D-RSC). Avidity is

May 20, 2025

The Critical Path Institute Podcast: eCOA Conversations with Florence Mowlem, Karl McEvoy, and Brian Lillis

Welcome to the latest Critical Path Institute Podcast episode—the first in the eCOA Conversations series.

Previous23 4...31 Next